Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
Japanese pharmaceutical company Eisai has established a new digital health business targeting dementia.
WHY IT MATTERS
Eisai's newly formed wholly-owned subsidiary, Theoria Technologies Co., seeks to "accelerate the development of a dementia ecosystem." This ecosystem, according to a press release, will empower people with dementia to "live their fullest lives."
Commencing business in April 2024...
TIIM Healthcare, an AI health technology company in Singapore, has received an exclusive IP license to commercialise a novel technology developed by the Duke-NUS Medical School to identify patients at risk of dying from sepsis.
Established in 2016, TIIM, which stands for Technology Innovation in Medicine, develops AI triaging solutions. Its flagship product, aiTRIAGE, incorporates both heart rate...
An international study led by Monash University has done what could be the world's first demonstration of an AI model that can predict the optimal anti-seizure medication for newly diagnosed epilepsy patients.
WHAT IT'S ABOUT
The research team has trained a deep-learning prediction model using clinical information from around 1,800 patients in five health care centres in Australia, Malaysia,...
Researchers from Nanyang Technological University have created a predictive computer programme that could be used to screen individuals for risk of depression.
WHAT IT'S ABOUT
The machine learning-enabled Ycogni model detects a person's risk of depression by analysing their physical activity, sleep patterns, and circadian rhythms, whose data are acquired from wearable devices measuring steps,...
Irish medtech giant Medtronic's subsidiary Medtronic India has entered into a strategic partnership with Statis Health, a unit of Stasis Labs, to promote the latter's bedside patient monitoring system in India.
WHAT IT DOES
The Stasis Monitor comprises a bedside monitor that tracks six vital signs, a tablet and a cloud-connected app that enables remote monitoring across devices.
The connected...
InteliCare was recently awarded an AU$100,000 grant (around $77,000) from the New South Wales Smart Sensing Network to enhance its machine learning capability. It received the grant along with partners Macquarie University and the University of Sydney.
The listed aged care technology developer will be working on a one-year project with NSSN and the Computer Science units of both universities....
This morning Medopad, an artificial intelligence-enabled patient data collection and analytics platform, landed $25 million in Series B funding. The last round was led by pharma giant Bayer’s venture capital branch Leaps by Bayer.
This new announcement brings the UK-based company’s total funding to $50 million, and comes roughly a year and a half after it closed its $28 million Series A round....
def4.jpg "Person answering their front door and getting a delivery from another person")
